A true multi-cancer early screening test
OncoSage is at the forefront of cancer detection technology, offering a revolutionary blood-based early cancer detection platform. Our mission is to provide healthcare professionals and patients with the tools they need to detect cancer at its earliest stages, when treatment is most effective.
Empowering Hope with Early Detection
Benefits and Features
Detect cancer before symptoms appear, improving treatment outcomes and survival rates.
A simple blood test that eliminates the need for invasive procedures.
Utilizes cutting-edge biomarker analysis and machine learning algorithms to ensure high accuracy and reliability.
Receive results quickly, allowing for timely medical interventions.
How it Works
A small blood sample is collected from the patient and platelets cells are isolated.
Our powerful AI tools analyze and generate a unique signature for the patient, identifying cancer type, subtype, and stage.
Comprehensive results are provided to healthcare providers, enabling informed decision-making.
Applications
Health care providers
Empower your practice with OncoSage's early detection capabilities. Improve patient outcomes by integrating our platform into your diagnostic workflow.
Patients
Take control of your health with early cancer detection. OncoSage provides peace of mind and the possibility of early intervention.
News & Updates
Beyond Off-the-Shelf: How Custom AI Ensures Security and Competitive Edge
- Comments Off on Beyond Off-the-Shelf: How Custom AI Ensures Security and Competitive Edge
Case Study: Automating Semiconductor Testing and Packaging with AI-Powered Solutions
- Comments Off on Case Study: Automating Semiconductor Testing and Packaging with AI-Powered Solutions
Copoly: Leading the Charge in Early Cancer Detection through Multi-Omics and AI
- Comments Off on Copoly: Leading the Charge in Early Cancer Detection through Multi-Omics and AI
Copoly Selected for Startup Showcase Talk at Collision 2024
- Comments Off on Copoly Selected for Startup Showcase Talk at Collision 2024
Addressing the Challenge: 50% of Cancers are Diagnosed Too Late
- Comments Off on Addressing the Challenge: 50% of Cancers are Diagnosed Too Late
Copoly Selected for ALPHA Program at Collision 2024 in Toronto
- Comments Off on Copoly Selected for ALPHA Program at Collision 2024 in Toronto
The Transformative Power of Early Cancer Detection in Improving Patient Outcomes
- Comments Off on The Transformative Power of Early Cancer Detection in Improving Patient Outcomes
Let's Connect
Want to discuss your needs, schedule a demo, form a collaboration, or ask us any questions? Our team is here to provide you with the support and information you need to make the most of our technology. Fill out the form to contact us, or use the calendar below to schedule a meeting with us!